HealthStream (HSTM) Financials

$32.70 +0.32 (+0.99%)

Closing price 04:00 PM Eastern

Extended Trading

$32.70 0.00 (0.00%)

As of 04:35 PM Eastern

Annual Income Statements for HealthStream

This table shows HealthStream's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	10	8.62	3.76	10	32	16	14	5.85	12	15	20
Consolidated Net Income / (Loss)	10	8.62	3.76	10	32	16	14	5.85	12	15	20
Net Income / (Loss) Continuing Operations	10	8.62	4.79	8.84	13	14	14	5.85	12	15	20
Total Pre-Tax Income	17	14	7.75	10	17	18	18	7.77	16	19	25
Total Operating Income	16	14	7.17	9.41	15	15	16	8.06	12	16	21
Total Gross Profit	97	120	117	128	136	150	155	166	176	184	194
Total Revenue	171	209	192	215	232	254	245	257	267	279	292
Operating Revenue	171	209	192	215	232	254	245	257	267	279	292
Total Cost of Revenue	74	89	75	87	96	104	89	91	91	95	98
Operating Cost of Revenue	74	89	75	87	96	104	89	91	91	95	98
Total Operating Expenses	80	106	110	118	120	136	140	158	163	168	172
Selling, General & Admin Expense	23	29	30	31	34	41	42	40	37	36	35
Marketing Expense	30	36	35	39	36	38	35	39	44	46	47
Research & Development Expense	16	24	24	24	26	29	32	42	44	46	49
Depreciation Expense	11	17	20	24	24	28	30	37	38	41	41
Total Other Income / (Expense), net	0.15	0.16	0.58	0.73	1.08	3.21	2.01	-0.29	3.14	2.49	3.52
Interest & Investment Income	-	-	-	-	-	-	-	-	0.44	2.36	3.83
Other Income / (Expense), net	0.15	0.16	0.58	0.73	1.08	3.21	2.01	-0.29	2.69	0.14	-0.32
Income Tax Expense	6.13	5.10	2.96	1.30	3.32	3.73	3.73	1.92	3.49	3.30	4.80
Basic Earnings per Share	$0.38	$0.29	$0.12	$0.31	$1.00	$0.49	$0.44	$0.19	$0.39	$0.50	$0.66
Weighted Average Basic Shares Outstanding	27.57M	30.06M	31.72M	31.86M	32.26M	32.37M	31.96M	31.53M	30.65M	30.57M	30.39M
Diluted Earnings per Share	$0.37	$0.28	$0.12	$0.31	$1.00	$0.49	$0.44	$0.18	$0.39	$0.50	$0.66
Weighted Average Diluted Shares Outstanding	28.02M	30.44M	32.07M	32.20M	32.34M	32.43M	31.99M	31.62M	30.72M	30.67M	30.54M
Weighted Average Basic & Diluted Shares Outstanding	27.40M	29.70M	31.30M	32.30M	32.20M	32.38M	31.49M	30.94M	30.58M	30.30M	30.43M
Cash Dividends to Common per Share	-	-	-	-	$1.00	-	-	$0.00	$0.00	$0.10	$0.11

This table shows HealthStream's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	3.67	2.45	2.62	4.13	3.87	4.59	5.23	4.17	5.73	4.89
Consolidated Net Income / (Loss)	3.67	2.45	2.62	4.13	3.87	4.59	5.23	4.17	5.73	4.89
Net Income / (Loss) Continuing Operations	3.67	2.45	2.62	4.13	3.87	4.59	5.23	4.17	5.73	4.89
Total Pre-Tax Income	4.93	3.27	3.14	4.50	5.45	5.42	6.54	5.30	7.48	5.48
Total Operating Income	2.38	3.08	2.89	4.01	4.86	4.26	5.69	4.41	6.50	4.69
Total Gross Profit	44	45	45	46	47	47	48	48	49	49
Total Revenue	67	69	69	69	70	71	73	72	73	74
Operating Revenue	67	69	69	69	70	71	73	72	73	74
Total Cost of Revenue	23	24	24	24	24	24	25	24	24	25
Operating Cost of Revenue	23	24	24	24	24	24	25	24	24	25
Total Operating Expenses	42	42	42	42	42	42	42	43	42	44
Selling, General & Admin Expense	9.10	9.01	8.87	9.06	9.30	8.44	8.31	9.56	8.46	8.81
Marketing Expense	11	11	12	11	11	11	12	11	11	12
Research & Development Expense	11	12	12	11	11	12	12	12	12	13
Depreciation Expense	9.59	9.61	9.93	10	10	11	10	10	10	10
Total Other Income / (Expense), net	2.54	0.19	0.25	0.49	0.59	1.16	0.85	0.89	0.98	0.79
Other Income / (Expense), net	2.54	-0.25	0.25	0.49	0.59	-1.20	0.85	0.89	0.98	-3.04
Income Tax Expense	1.26	0.82	0.52	0.37	1.59	0.83	1.32	1.13	1.75	0.59
Basic Earnings per Share	$0.12	$0.08	$0.09	$0.13	$0.13	$0.15	$0.17	$0.14	$0.19	$0.16
Weighted Average Basic Shares Outstanding	30.57M	30.65M	30.59M	30.68M	30.68M	30.57M	30.31M	30.40M	30.41M	30.39M
Diluted Earnings per Share	$0.12	$0.08	$0.09	$0.13	$0.13	$0.15	$0.17	$0.14	$0.19	$0.16
Weighted Average Diluted Shares Outstanding	30.66M	30.72M	30.66M	30.78M	30.77M	30.67M	30.42M	30.53M	30.59M	30.54M
Weighted Average Basic & Diluted Shares Outstanding	30.57M	30.58M	30.68M	30.69M	30.29M	30.30M	30.40M	30.41M	30.41M	30.43M
Cash Dividends to Common per Share	$0.00	-	$0.03	$0.03	$0.03	$0.03	$0.03	$0.03	$0.03	$0.03

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	22	0.02	-32	35	50	-2.78	-95	10	-0.88	-5.69	19
Net Cash From Operating Activities	34	35	24	47	43	66	36	42	51	64	58
Net Cash From Continuing Operating Activities	34	35	24	43	44	66	36	42	51	64	58
Net Income / (Loss) Continuing Operations	10	8.62	4.79	8.84	13	14	14	5.85	12	15	20
Consolidated Net Income / (Loss)	10	8.62	3.76	10	32	16	14	5.85	12	15	20
Depreciation Expense	11	17	20	24	24	28	30	37	38	41	41
Amortization Expense	-	-	-	-	7.66	8.31	8.77	9.17	11	11	12
Non-Cash Adjustments To Reconcile Net Income	0.09	2.00	3.17	3.72	4.03	4.32	-1.73	5.40	1.07	4.24	5.66
Changes in Operating Assets and Liabilities, net	13	7.30	-4.44	6.00	-4.92	11	-15	-15	-11	-8.06	-22
Net Cash From Investing Activities	-16	-135	-57	-12	37	-68	-110	-26	-28	-57	-34
Net Cash From Continuing Investing Activities	-16	-135	-56	-8.82	37	-68	-110	-26	-28	-57	-34
Purchase of Property, Plant & Equipment	-10	-15	-14	-15	-18	-37	-19	-25	-25	-28	-28
Acquisitions	-13	-89	-55	-0.50	0.00	-27	-121	-4.71	-3.97	-6.62	-1.30
Purchase of Investments	-45	-85	-107	-83	-58	-91	-62	-6.97	-13	-50	-74
Sale of Property, Plant & Equipment	-	-	0.98	-	0.00	0.02	0.00	0.00	0.03	0.00	0.00
Sale and/or Maturity of Investments	53	55	119	90	69	81	92	11	14	28	70
Net Cash From Financing Activities	3.74	100	0.05	0.00	-30	-0.92	-20	-6.21	-24	-13	-4.52
Net Cash From Continuing Financing Activities	3.74	100	0.05	0.00	-30	-0.92	-20	-6.21	-24	-13	-4.52
Repayment of Debt	-	-28	-	-	-0.10	-	-	0.00	0.00	-0.12	0.00
Repurchase of Common Equity	-	-	-	-	0.00	0.00	-20	-5.01	-23	-8.93	0.00
Payment of Dividends	-0.42	-0.63	-	-	-32	-0.10	-0.04	-0.02	0.00	-3.06	-3.40
Other Financing Activities, net	4.17	2.58	0.05	0.00	2.24	-0.82	-0.44	-1.18	-0.57	-0.93	-1.11
Effect of Exchange Rate Changes	-	-	-	-	-	-	0.06	-0.11	0.02	-0.02	-0.04
Cash Interest Paid	0.06	0.19	0.08	0.10	0.12	0.10	0.10	0.13	0.10	0.13	0.10
Cash Income Taxes Paid	1.64	2.65	2.50	0.64	17	0.63	0.88	-0.09	0.72	2.61	8.70

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	11	-2.23	2.81	-23	18	-3.79	12	-6.28	11	1.98
Net Cash From Operating Activities	15	8.11	21	4.95	25	14	21	6.45	19	11
Net Cash From Continuing Operating Activities	15	8.11	21	4.95	25	14	21	6.45	19	11
Net Income / (Loss) Continuing Operations	3.67	2.45	2.62	4.13	3.87	4.59	5.23	4.17	5.72	4.89
Consolidated Net Income / (Loss)	3.67	2.45	2.62	4.13	3.87	4.59	5.23	4.17	5.72	4.89
Depreciation Expense	9.59	9.61	9.93	10	10	11	10	10	10	10
Amortization Expense	2.80	2.77	2.71	2.75	3.00	3.03	2.96	3.00	3.10	3.42
Non-Cash Adjustments To Reconcile Net Income	-1.67	1.03	1.20	1.11	1.13	0.81	0.92	2.37	0.97	1.40
Changes in Operating Assets and Liabilities, net	0.71	-7.75	4.08	-13	6.27	-5.14	1.50	-13	-0.76	-9.01
Net Cash From Investing Activities	-4.05	-10	-17	-26	-3.92	-9.38	-7.12	-12	-6.87	-8.07
Net Cash From Continuing Investing Activities	-4.05	-10	-17	-26	-3.92	-9.38	-7.12	-12	-6.87	-8.07
Purchase of Property, Plant & Equipment	-5.96	-6.14	-8.45	-6.25	-6.72	-6.60	-7.76	-6.71	-6.84	-6.84
Acquisitions	-	0.04	-6.62	-	-	-	0.00	-	-	-1.30
Purchase of Investments	-3.58	-7.87	-2.85	-29	-6.25	-12	-14	-20	-17	-23
Sale and/or Maturity of Investments	5.49	3.60	1.00	9.00	9.05	9.25	15	15	17	23
Net Cash From Financing Activities	-0.02	-0.05	-0.79	-1.54	-2.44	-8.27	-1.70	-0.86	-0.92	-1.03
Net Cash From Continuing Financing Activities	-0.02	-0.05	-0.79	-1.54	-2.44	-8.27	-1.70	-0.86	-0.92	-1.03
Payment of Dividends	-	-	0.00	-1.53	-0.77	-0.76	-0.85	-0.85	-0.85	-0.85
Other Financing Activities, net	-0.02	-0.05	-0.79	-0.01	-0.02	-0.12	-0.86	-0.01	-0.07	-0.18
Effect of Exchange Rate Changes	0.01	0.07	-0.02	-0.06	0.01	0.05	-0.04	0.04	0.04	-0.08

This table presents HealthStream's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2020	2021	2022	2023	2024
Total Assets	257	380	396	411	442	500	487	498	500	511
Total Current Assets	175	210	177	200	241	115	107	114	130	153
Cash & Equivalents	82	82	50	85	134	37	47	46	40	59
Short-Term Investments	39	67	54	46	34	9.93	5.04	7.89	31	38
Accounts Receivable	33	36	47	38	41	46	35	43	38	35
Prepaid Expenses	13	14	18	16	14	9.57	9.16	15	18	18
Other Current Assets	5.77	8.17	8.69	8.33	18	13	11	2.65	3.03	2.47
Plant, Property, & Equipment, net	9.44	12	10	8.09	16	22	18	15	13	11
Total Noncurrent Assets	73	158	208	203	185	363	362	368	357	347
Goodwill	42	83	110	86	86	178	183	192	191	191
Intangible Assets	28	70	95	85	78	127	122	119	109	99
Other Noncurrent Operating Assets	2.04	0.93	0.60	0.75	17	50	50	52	57	57
Total Liabilities & Shareholders' Equity	257	380	396	411	442	500	487	498	500	511
Total Liabilities	89	99	110	111	123	166	148	164	159	151
Total Current Liabilities	77	89	95	101	107	119	100	117	118	116
Accounts Payable	4.75	4.62	3.13	4.18	8.50	9.33	5.13	7.29	7.47	6.63
Accrued Expenses	16	16	21	22	32	29	21	30	18	15
Current Deferred Revenue	54	65	69	65	66	81	74	79	84	84
Current Employee Benefit Liabilities	2.31	3.31	1.99	2.76	-	-	-	-	9.49	9.51
Total Noncurrent Liabilities	12	10	15	9.88	16	47	47	46	41	36
Noncurrent Deferred Revenue	3.66	4.35	7.86	6.29	2.87	1.60	1.58	2.94	2.17	1.66
Noncurrent Deferred & Payable Income Tax Liabilities	5.84	4.76	5.97	-	11	15	18	18	16	15
Other Noncurrent Operating Liabilities	2.65	1.06	1.10	1.05	2.21	31	28	26	23	19
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	168	280	286	300	319	334	339	334	341	359
Total Preferred & Common Equity	168	280	286	300	319	334	339	334	341	359
Preferred Stock	-	-	-	-	-	-	-	-	0.00	0.00
Total Common Equity	168	280	286	300	319	334	339	334	341	359
Common Stock	175	279	281	283	287	272	271	255	249	252
Retained Earnings	-7.03	1.59	5.35	18	32	62	68	80	92	109
Accumulated Other Comprehensive Income / (Loss)	-0.04	-0.07	-0.05	-0.04	-0.02	0.00	0.11	-0.98	-0.69	-2.05

This table presents HealthStream's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	481	503	493	498	512	500	503
Total Current Assets	104	125	118	127	147	139	146
Cash & Equivalents	48	49	26	44	52	46	57
Short-Term Investments	3.59	9.82	30	28	31	37	37
Accounts Receivable	33	47	41	35	44	36	32
Prepaid Expenses	9.26	11	9.88	11	18	17	16
Other Current Assets	11	8.21	11	9.51	2.09	3.12	3.16
Plant, Property, & Equipment, net	16	15	14	14	13	12	11
Total Noncurrent Assets	361	363	361	358	352	349	346
Long-Term Investments	4.64	4.39	4.28	4.19	4.10	4.05	3.98
Goodwill	188	191	191	191	191	191	191
Intangible Assets	117	118	114	111	106	103	100
Other Noncurrent Operating Assets	51	50	51	51	51	51	51
Total Liabilities & Shareholders' Equity	481	503	493	498	512	500	503
Total Liabilities	151	167	153	156	167	150	147
Total Current Liabilities	105	121	109	115	126	112	111
Accounts Payable	22	20	22	3.52	5.31	5.81	4.44
Accrued Expenses	5.61	6.53	5.24	28	22	19	23
Current Deferred Revenue	78	94	82	83	98	87	83
Total Noncurrent Liabilities	46	46	44	41	41	38	37
Capital Lease Obligations	-	-	-	-	19	19	18
Noncurrent Deferred Revenue	1.26	2.56	2.26	2.74	2.08	1.89	1.67
Noncurrent Deferred & Payable Income Tax Liabilities	19	19	17	15	17	16	15
Other Noncurrent Operating Liabilities	26	25	24	23	2.25	2.22	1.99
Total Equity & Noncontrolling Interests	330	336	341	342	345	349	355
Total Preferred & Common Equity	330	336	341	342	345	349	355
Total Common Equity	330	336	341	342	345	349	355
Common Stock	254	255	256	255	249	250	251
Retained Earnings	78	82	85	89	97	100	105
Accumulated Other Comprehensive Income / (Loss)	-1.42	-1.02	-0.89	-1.24	-1.17	-1.22	-0.88

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	29.04%	22.45%	-8.08%	11.85%	7.78%	9.71%	-3.65%	4.85%	3.94%	4.59%	4.51%
EBITDA Growth	20.97%	11.89%	-8.46%	21.58%	41.76%	11.63%	4.95%	-5.34%	18.49%	7.92%	8.68%
EBIT Growth	11.31%	-16.96%	-43.49%	30.81%	63.46%	8.17%	-0.59%	-56.43%	94.97%	6.70%	29.80%
NOPAT Growth	23.85%	-17.31%	-47.98%	85.00%	51.05%	-5.89%	7.30%	-51.52%	59.31%	36.31%	30.43%
Net Income Growth	23.47%	-17.06%	-56.44%	166.42%	222.04%	-51.05%	-10.65%	-58.52%	106.86%	25.82%	31.51%
EPS Growth	23.33%	-24.32%	-57.14%	158.33%	222.58%	-51.00%	-10.20%	-59.09%	116.67%	28.21%	32.00%
Operating Cash Flow Growth	26.62%	1.93%	-30.60%	92.75%	-7.42%	51.82%	-45.36%	18.15%	20.77%	24.97%	-9.86%
Free Cash Flow Firm Growth	-8.50%	-1,353.20%	35.80%	199.84%	-87.29%	-50.03%	-3,841.91%	105.99%	107.98%	36.54%	28.50%
Invested Capital Growth	10.79%	182.92%	40.69%	-21.85%	4.52%	5.89%	80.65%	-0.25%	-1.57%	-2.18%	-2.77%
Revenue Q/Q Growth	5.10%	5.30%	-13.89%	16.47%	2.01%	1.14%	-0.36%	0.99%	1.60%	0.74%	1.27%
EBITDA Q/Q Growth	6.37%	-1.13%	-4.44%	7.37%	24.50%	2.88%	-3.01%	-0.73%	6.83%	1.42%	-4.40%
EBIT Q/Q Growth	4.37%	-13.86%	-9.86%	5.88%	13.08%	1.92%	-13.92%	-17.39%	28.13%	-1.27%	-15.24%
NOPAT Q/Q Growth	9.55%	-9.77%	-18.61%	36.77%	-4.89%	6.10%	-14.06%	-17.47%	38.42%	11.04%	3.34%
Net Income Q/Q Growth	9.33%	-8.82%	-36.12%	74.16%	-3.47%	6.00%	-16.38%	-18.31%	30.64%	16.38%	1.51%
EPS Q/Q Growth	12.12%	-15.15%	-33.33%	72.22%	-2.91%	8.89%	-18.52%	-21.74%	34.48%	16.28%	1.54%
Operating Cash Flow Q/Q Growth	5.34%	12.27%	-0.60%	4.00%	8.52%	-1.99%	-18.21%	1.99%	4.40%	9.79%	-4.40%
Free Cash Flow Firm Q/Q Growth	87.88%	2.61%	-1.57%	136.75%	-86.12%	155.44%	-954.31%	107.83%	116.51%	-1.14%	196.57%
Invested Capital Q/Q Growth	0.70%	-1.99%	-1.58%	-16.67%	6.32%	0.61%	56.22%	2.46%	0.67%	1.27%	-4.52%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.56%	57.23%	60.98%	59.42%	58.55%	59.12%	63.51%	64.54%	65.84%	65.95%	66.42%
EBITDA Margin	16.08%	14.70%	14.64%	15.91%	20.92%	21.29%	23.19%	20.94%	23.87%	24.63%	25.61%
Operating Margin	9.59%	6.49%	3.73%	4.38%	6.69%	5.79%	6.46%	3.14%	4.67%	5.74%	7.30%
EBIT Margin	9.68%	6.56%	4.03%	4.72%	7.16%	7.06%	7.28%	3.03%	5.67%	5.79%	7.19%
Profit (Net Income) Margin	6.09%	4.12%	1.95%	4.66%	13.91%	6.21%	5.76%	2.28%	4.53%	5.45%	6.86%
Tax Burden Percent	62.91%	62.84%	48.44%	98.66%	194.37%	87.96%	79.06%	75.26%	77.58%	82.18%	80.66%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	102.93%	114.58%	118.28%
Effective Tax Rate	37.09%	37.16%	38.20%	12.84%	20.05%	20.82%	20.94%	24.74%	22.42%	17.82%	19.34%
Return on Invested Capital (ROIC)	23.99%	9.86%	2.88%	5.12%	8.63%	7.71%	5.74%	2.16%	3.48%	4.83%	6.46%
ROIC Less NNEP Spread (ROIC-NNEP)	23.91%	9.78%	3.41%	3.77%	-3.32%	-41.27%	8.84%	2.55%	-0.67%	1.67%	3.09%
Return on Net Nonoperating Assets (RNNOA)	-17.44%	-6.01%	-1.56%	-1.71%	1.78%	2.17%	2.70%	-0.43%	0.12%	-0.32%	-0.74%
Return on Equity (ROE)	6.55%	3.85%	1.33%	3.41%	10.41%	9.89%	8.44%	1.74%	3.59%	4.51%	5.72%
Cash Return on Invested Capital (CROIC)	13.76%	-85.68%	-30.93%	29.65%	4.20%	2.00%	-51.74%	2.41%	5.06%	7.04%	9.27%
Operating Return on Assets (OROA)	7.03%	4.31%	2.00%	2.51%	3.89%	3.85%	3.60%	1.57%	3.08%	3.24%	4.15%
Return on Assets (ROA)	4.42%	2.71%	0.97%	2.48%	7.55%	3.39%	2.85%	1.18%	2.46%	3.05%	3.96%
Return on Common Equity (ROCE)	6.55%	3.85%	1.33%	3.41%	10.41%	9.89%	8.44%	1.74%	3.59%	4.51%	5.72%
Return on Equity Simple (ROE_SIMPLE)	6.19%	3.08%	1.31%	3.33%	10.10%	0.00%	4.22%	1.72%	3.62%	4.46%	5.57%
Net Operating Profit after Tax (NOPAT)	10	8.52	4.43	8.20	12	12	13	6.06	9.66	13	17
NOPAT Margin	6.04%	4.08%	2.31%	3.82%	5.35%	4.59%	5.11%	2.36%	3.62%	4.72%	5.89%
Net Nonoperating Expense Percent (NNEP)	0.08%	0.07%	-0.52%	1.36%	11.95%	48.98%	-3.11%	-0.39%	4.14%	3.16%	3.37%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	2.89%	3.86%	4.78%
Cost of Revenue to Revenue	43.44%	42.77%	39.02%	40.58%	41.45%	40.88%	36.49%	35.46%	34.16%	34.05%	33.58%
SG&A Expenses to Revenue	13.42%	14.00%	15.85%	14.65%	14.87%	15.97%	17.11%	15.46%	13.82%	12.78%	12.05%
R&D to Revenue	9.65%	11.59%	12.61%	11.24%	11.11%	11.46%	13.20%	16.23%	16.59%	16.32%	16.76%
Operating Expenses to Revenue	46.97%	50.75%	57.25%	55.04%	51.86%	53.32%	57.05%	61.40%	61.18%	60.21%	59.12%
Earnings before Interest and Taxes (EBIT)	17	14	7.75	10	17	18	18	7.77	15	16	21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	27	31	28	34	48	54	57	54	64	69	75
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.62	2.37	2.65	2.34	2.43	2.59	2.06	2.44	2.26	2.39	2.69
Price to Tangible Book Value (P/TBV)	7.88	5.21	9.27	5.43	5.00	5.66	24.29	23.67	32.76	20.03	13.97
Price to Revenue (P/Rev)	4.55	3.17	3.94	3.27	3.35	3.44	2.81	3.22	2.82	2.92	3.32
Price to Earnings (P/E)	74.65	76.91	201.66	70.33	24.06	55.45	48.75	141.33	62.31	53.60	48.34
Dividend Yield	0.00%	0.00%	0.00%	0.00%	4.17%	0.00%	0.00%	0.00%	0.00%	0.37%	0.43%
Earnings Yield	1.34%	1.30%	0.50%	1.42%	4.16%	1.80%	2.05%	0.71%	1.61%	1.87%	2.07%
Enterprise Value to Invested Capital (EV/IC)	14.47	4.00	3.62	4.05	4.11	4.47	2.26	2.74	2.52	2.76	3.32
Enterprise Value to Revenue (EV/Rev)	3.83	2.44	3.39	2.65	2.60	2.73	2.59	2.99	2.60	2.67	2.98
Enterprise Value to EBITDA (EV/EBITDA)	23.79	16.62	23.15	16.63	12.44	12.84	11.16	14.27	10.91	10.83	11.65
Enterprise Value to EBIT (EV/EBIT)	39.54	37.21	83.95	56.08	36.38	38.75	35.55	98.78	45.90	46.07	41.49
Enterprise Value to NOPAT (EV/NOPAT)	63.40	59.92	146.84	69.36	48.69	59.61	50.67	126.53	71.95	56.53	50.67
Enterprise Value to Operating Cash Flow (EV/OCF)	19.07	14.62	26.85	12.17	13.94	10.58	17.66	18.10	13.58	11.63	15.09
Enterprise Value to Free Cash Flow (EV/FCFF)	110.55	0.00	0.00	11.98	99.93	230.44	0.00	113.55	49.46	38.79	35.29
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.73	-0.61	-0.46	-0.45	-0.54	-0.05	0.31	-0.17	-0.17	-0.19	-0.24
Leverage Ratio	1.48	1.42	1.37	1.38	1.38	2.92	2.96	1.47	1.46	1.48	1.44
Compound Leverage Factor	1.48	1.42	1.37	1.38	1.38	2.92	2.96	1.47	1.51	1.69	1.71
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	0.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	6.50	5.07	4.95	4.76	4.90	0.00	3.25	4.15	3.62	4.03	4.93
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.26	2.35	1.87	1.98	2.26	2.14	0.96	1.06	0.98	1.10	1.32
Quick Ratio	2.02	2.10	1.59	1.67	1.96	1.93	0.78	0.87	0.82	0.93	1.15
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	5.91	-74	-48	47	6.03	3.02	-113	6.76	14	19	25
Operating Cash Flow to CapEx	335.78%	227.34%	189.18%	309.11%	234.40%	179.91%	190.79%	167.23%	204.13%	228.42%	204.89%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.73	0.66	0.50	0.53	0.54	0.55	0.49	0.52	0.54	0.56	0.58
Accounts Receivable Turnover	5.84	6.01	4.59	5.03	5.86	7.12	6.40	6.34	6.87	6.88	7.91
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	18.47	19.08	16.92	23.44	19.34	0.00	0.00	12.78	15.96	19.59	24.56
Accounts Payable Turnover	20.99	19.08	19.36	23.88	15.15	0.00	0.00	12.59	14.69	12.88	13.90
Days Sales Outstanding (DSO)	62.53	60.70	79.54	72.53	62.26	51.26	57.01	57.60	53.10	53.07	46.16
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	17.39	19.13	18.85	15.29	24.09	0.00	0.00	28.99	24.86	28.33	26.26
Cash Conversion Cycle (CCC)	45.14	41.57	60.69	57.24	38.17	51.26	57.01	28.61	28.24	24.74	19.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	45	128	180	140	147	155	281	280	276	270	262
Invested Capital Turnover	3.98	2.42	1.25	1.34	1.61	1.68	1.12	0.92	0.96	1.02	1.10
Increase / (Decrease) in Invested Capital	4.39	83	52	-39	6.35	8.64	125	-0.69	-4.39	-6.02	-7.48
Enterprise Value (EV)	653	510	651	569	603	695	634	767	695	744	870
Market Capitalization	776	663	757	704	775	874	687	826	753	815	967
Book Value per Share	$6.07	$8.86	$9.01	$9.41	$9.87	$0.00	$10.55	$10.74	$10.93	$11.25	$11.82
Tangible Book Value per Share	$3.56	$4.02	$2.57	$4.06	$4.80	$0.00	$0.89	$1.11	$0.75	$1.34	$2.28
Total Capital	168	280	286	300	319	0.00	334	339	334	341	359
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-123	-153	-106	-135	-172	-180	-53	-59	-58	-71	-97
Capital Expenditures (CapEx)	10	15	13	15	18	36	19	25	25	28	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-24	-29	-21	-32	-34	-53	-51	-45	-57	-59	-60
Debt-free Net Working Capital (DFNWC)	97	120	82	99	135	119	-4.72	6.50	-2.84	12	37
Net Working Capital (NWC)	97	120	82	99	135	119	-4.72	6.50	-2.84	12	37
Net Nonoperating Expense (NNE)	-0.09	-0.10	0.68	-1.80	-20	-4.11	-1.59	0.22	-2.43	-2.05	-2.84
Net Nonoperating Obligations (NNO)	-123	-153	-106	-160	-172	155	-53	-59	-58	-71	-97
Total Depreciation and Amortization (D&A)	11	17	20	24	32	36	39	46	49	53	54
Debt-free, Cash-free Net Working Capital to Revenue	-13.84%	-13.65%	-10.78%	-15.10%	-14.78%	-21.05%	-20.92%	-17.71%	-21.27%	-21.24%	-20.50%
Debt-free Net Working Capital to Revenue	57.03%	57.64%	42.92%	45.91%	58.10%	46.98%	-1.93%	2.53%	-1.06%	4.25%	12.83%
Net Working Capital to Revenue	57.03%	57.64%	42.92%	45.91%	58.10%	46.98%	-1.93%	2.53%	-1.06%	4.25%	12.83%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.38	$0.29	$0.12	$0.31	$1.00	$0.49	$0.44	$0.19	$0.39	$0.50	$0.66
Adjusted Weighted Average Basic Shares Outstanding	27.57M	30.06M	31.72M	31.86M	32.26M	32.37M	31.96M	31.53M	30.65M	30.57M	30.39M
Adjusted Diluted Earnings per Share	$0.37	$0.28	$0.12	$0.31	$1.00	$0.49	$0.44	$0.18	$0.39	$0.50	$0.66
Adjusted Weighted Average Diluted Shares Outstanding	28.02M	30.44M	32.07M	32.20M	32.34M	32.43M	31.99M	31.62M	30.72M	30.67M	30.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.68M	31.65M	31.78M	32.04M	32.33M	32.38M	31.49M	30.94M	30.58M	30.30M	30.43M
Normalized Net Operating Profit after Tax (NOPAT)	10	8.52	4.43	8.20	12	12	13	6.06	9.66	13	17
Normalized NOPAT Margin	6.04%	4.08%	2.31%	3.82%	5.35%	4.59%	5.11%	2.36%	3.62%	4.72%	5.89%
Pre Tax Income Margin	9.68%	6.56%	4.03%	4.72%	7.16%	7.06%	7.28%	3.03%	5.84%	6.63%	8.50%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	4.08%	7.34%	0.00%	0.00%	100.55%	0.61%	0.28%	0.33%	0.00%	20.10%	17.01%
Augmented Payout Ratio	4.08%	7.34%	0.00%	0.00%	100.55%	0.61%	142.35%	86.01%	191.36%	78.79%	17.01%

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.98%	6.53%	5.48%	5.42%	4.54%	2.98%	5.53%	3.41%	3.92%	5.18%
EBITDA Growth	30.99%	36.53%	1.37%	12.03%	8.92%	9.24%	25.71%	6.84%	9.53%	-6.52%
EBIT Growth	192.11%	666.13%	-16.44%	23.90%	10.72%	8.35%	108.31%	17.78%	37.15%	-46.19%
NOPAT Growth	11.65%	814.80%	-22.26%	46.86%	94.50%	56.38%	88.28%	-5.77%	44.23%	15.88%
Net Income Growth	144.40%	732.82%	-9.33%	34.06%	5.48%	87.42%	99.28%	0.85%	48.05%	6.47%
EPS Growth	140.00%	500.00%	0.00%	30.00%	8.33%	87.50%	88.89%	7.69%	46.15%	6.67%
Operating Cash Flow Growth	24.66%	36.29%	-0.55%	-32.46%	63.38%	70.35%	1.93%	30.38%	-22.53%	-19.20%
Free Cash Flow Firm Growth	101.40%	1,708.98%	-102.67%	315.33%	755.87%	43.70%	739.23%	-39.74%	-130.28%	21.14%
Invested Capital Growth	0.18%	-1.57%	0.95%	-0.41%	-2.76%	-2.18%	1.31%	0.20%	3.12%	-2.77%
Revenue Q/Q Growth	2.51%	1.86%	0.60%	0.37%	1.65%	0.34%	3.09%	-1.65%	2.15%	1.56%
EBITDA Q/Q Growth	11.01%	-12.16%	0.81%	10.74%	7.92%	-11.89%	4.56%	-5.88%	10.64%	-24.81%
EBIT Q/Q Growth	35.60%	-42.64%	-3.92%	43.27%	21.18%	-43.87%	20.79%	-19.00%	41.11%	-77.98%
NOPAT Q/Q Growth	-29.26%	30.09%	4.66%	52.48%	-6.32%	4.60%	26.02%	-23.69%	43.39%	-15.97%
Net Income Q/Q Growth	18.91%	-33.20%	7.10%	57.57%	-6.44%	18.70%	13.88%	-20.26%	37.36%	-14.64%
EPS Q/Q Growth	20.00%	-33.33%	12.50%	44.44%	0.00%	15.38%	13.33%	-17.65%	35.71%	-15.79%
Operating Cash Flow Q/Q Growth	106.10%	-46.30%	153.34%	-75.91%	398.57%	-44.01%	51.59%	-69.19%	196.25%	-41.60%
Free Cash Flow Firm Q/Q Growth	157.36%	421.26%	-102.28%	3,257.75%	127.99%	-12.48%	115.05%	197.66%	-214.55%	450.19%
Invested Capital Q/Q Growth	-2.75%	0.67%	-0.96%	2.71%	-5.04%	1.27%	-3.21%	1.58%	-2.28%	-4.52%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.26%	65.66%	65.40%	65.94%	66.47%	65.98%	66.17%	66.83%	66.52%	66.17%
EBITDA Margin	25.73%	22.19%	22.89%	25.25%	26.81%	23.54%	27.26%	26.09%	28.26%	20.92%
Operating Margin	3.54%	4.49%	4.19%	5.79%	6.91%	6.03%	7.82%	6.16%	8.89%	6.32%
EBIT Margin	7.32%	4.12%	4.56%	6.50%	7.75%	4.34%	8.99%	7.41%	10.23%	2.22%
Profit (Net Income) Margin	5.45%	3.57%	3.80%	5.97%	5.50%	6.50%	7.18%	5.82%	7.83%	6.58%
Tax Burden Percent	74.44%	74.92%	83.51%	91.84%	70.92%	84.73%	79.89%	78.64%	76.55%	89.16%
Interest Burden Percent	100.00%	115.72%	100.00%	100.00%	100.00%	176.97%	100.00%	100.00%	100.00%	332.79%
Effective Tax Rate	25.56%	25.08%	16.49%	8.16%	29.08%	15.27%	20.11%	21.36%	23.45%	10.84%
Return on Invested Capital (ROIC)	2.53%	3.23%	3.48%	5.19%	5.03%	5.23%	6.43%	4.93%	7.25%	6.18%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.49%	2.99%	3.12%	4.33%	4.40%	3.71%	5.39%	3.84%	6.29%	5.34%
Return on Net Nonoperating Assets (RNNOA)	0.09%	-0.52%	-0.55%	-0.68%	-0.87%	-0.71%	-1.04%	-0.72%	-1.41%	-1.28%
Return on Equity (ROE)	2.62%	2.71%	2.94%	4.50%	4.16%	4.52%	5.39%	4.21%	5.83%	4.89%
Cash Return on Invested Capital (CROIC)	2.37%	5.06%	2.34%	3.98%	7.19%	7.04%	4.27%	5.18%	3.07%	9.27%
Operating Return on Assets (OROA)	3.94%	2.23%	2.50%	3.67%	4.39%	2.43%	5.01%	4.26%	5.89%	1.28%
Return on Assets (ROA)	2.93%	1.94%	2.08%	3.37%	3.11%	3.64%	4.01%	3.35%	4.51%	3.80%
Return on Common Equity (ROCE)	2.62%	2.71%	2.94%	4.50%	4.16%	4.52%	5.39%	4.21%	5.83%	4.89%
Return on Equity Simple (ROE_SIMPLE)	2.80%	0.00%	3.52%	3.78%	3.82%	0.00%	5.17%	5.11%	5.54%	0.00%
Net Operating Profit after Tax (NOPAT)	1.77	2.31	2.41	3.68	3.45	3.61	4.55	3.47	4.97	4.18
NOPAT Margin	2.64%	3.37%	3.50%	5.32%	4.90%	5.11%	6.25%	4.85%	6.80%	5.63%
Net Nonoperating Expense Percent (NNEP)	3.02%	0.24%	0.36%	0.86%	0.63%	1.52%	1.04%	1.09%	0.96%	0.84%
Return On Investment Capital (ROIC_SIMPLE)	-	0.69%	-	-	-	1.06%	-	-	-	1.16%
Cost of Revenue to Revenue	34.74%	34.34%	34.60%	34.06%	33.53%	34.02%	33.83%	33.17%	33.48%	33.83%
SG&A Expenses to Revenue	13.52%	13.14%	12.86%	13.10%	13.21%	11.96%	11.42%	13.35%	11.57%	11.86%
R&D to Revenue	17.06%	17.23%	16.94%	15.94%	15.50%	16.90%	16.54%	16.88%	16.55%	17.08%
Operating Expenses to Revenue	61.72%	61.16%	61.21%	60.15%	59.55%	59.95%	58.35%	60.66%	57.63%	59.86%
Earnings before Interest and Taxes (EBIT)	4.93	2.83	3.14	4.50	5.45	3.06	6.54	5.30	7.48	1.65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	17	15	16	17	19	17	20	19	21	16
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.95	2.26	2.45	2.20	1.93	2.39	2.34	2.43	2.47	2.69
Price to Tangible Book Value (P/TBV)	25.96	32.76	30.07	21.45	16.52	20.03	16.71	15.26	13.72	13.97
Price to Revenue (P/Rev)	2.46	2.82	3.04	2.74	2.38	2.92	2.85	2.97	3.05	3.32
Price to Earnings (P/E)	69.73	62.31	69.61	58.25	50.46	53.60	45.23	47.46	44.49	48.34
Dividend Yield	0.00%	0.00%	0.00%	0.20%	0.35%	0.37%	0.48%	0.47%	0.46%	0.43%
Earnings Yield	1.43%	1.61%	1.44%	1.72%	1.98%	1.87%	2.21%	2.11%	2.25%	2.07%
Enterprise Value to Invested Capital (EV/IC)	2.15	2.52	2.78	2.46	2.19	2.76	2.67	2.77	2.90	3.32
Enterprise Value to Revenue (EV/Rev)	2.24	2.60	2.81	2.52	2.11	2.67	2.61	2.73	2.76	2.98
Enterprise Value to EBITDA (EV/EBITDA)	9.88	10.91	11.81	10.41	8.61	10.83	9.82	10.21	10.19	11.65
Enterprise Value to EBIT (EV/EBIT)	49.83	45.90	50.77	43.54	35.66	46.07	33.66	34.30	32.18	41.49
Enterprise Value to NOPAT (EV/NOPAT)	84.39	71.95	85.10	68.63	49.22	56.53	48.20	51.57	47.91	50.67
Enterprise Value to Operating Cash Flow (EV/OCF)	12.01	13.58	14.88	14.16	10.02	11.63	11.46	11.83	13.20	15.09
Enterprise Value to Free Cash Flow (EV/FCFF)	90.74	49.46	119.44	61.62	30.07	38.79	62.87	53.56	95.77	35.29
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.05	0.05	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.05	0.05	0.00
Financial Leverage	-0.19	-0.17	-0.17	-0.16	-0.20	-0.19	-0.19	-0.19	-0.22	-0.24
Leverage Ratio	1.45	1.46	1.50	1.46	1.46	1.48	1.49	1.44	1.43	1.44
Compound Leverage Factor	1.45	1.69	1.50	1.46	1.46	2.62	1.49	1.44	1.43	4.80
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.35%	5.10%	4.81%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.35%	5.10%	4.81%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	94.65%	94.90%	95.19%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.26	0.25	0.23	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.91	-0.89	-1.04	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.26	0.25	0.23	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	1.27	1.24	1.08	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-4.46	-4.52	-4.87	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	1.27	1.24	1.08	0.00
Altman Z-Score	3.37	3.54	3.75	3.79	3.41	3.94	3.81	4.33	4.57	4.80
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.99	0.98	1.03	1.08	1.11	1.10	1.17	1.24	1.32	1.32
Quick Ratio	0.80	0.82	0.88	0.89	0.93	0.93	1.01	1.07	1.14	1.15
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1.29	6.70	-0.15	4.82	11	9.63	0.98	2.91	-3.33	12
Operating Cash Flow to CapEx	253.17%	132.05%	243.23%	79.22%	367.37%	209.27%	269.78%	96.21%	279.44%	163.23%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.54	0.54	0.55	0.56	0.57	0.56	0.56	0.57	0.58	0.58
Accounts Receivable Turnover	8.28	6.87	6.14	7.23	8.21	6.88	6.19	7.40	8.66	7.91
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	15.45	15.96	17.03	17.71	18.98	19.59	20.78	21.66	23.39	24.56
Accounts Payable Turnover	4.09	14.69	4.91	4.66	7.35	12.88	7.53	6.87	24.32	13.90
Days Sales Outstanding (DSO)	44.07	53.10	59.44	50.48	44.45	53.07	58.93	49.31	42.13	46.16
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	89.32	24.86	74.36	78.35	49.64	28.33	48.46	53.16	15.01	26.26
Cash Conversion Cycle (CCC)	-45.25	28.24	-14.91	-27.87	-5.18	24.74	10.47	-3.85	27.12	19.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	274	276	273	280	266	270	277	281	275	262
Invested Capital Turnover	0.96	0.96	1.00	0.98	1.03	1.02	1.03	1.02	1.07	1.10
Increase / (Decrease) in Invested Capital	0.49	-4.39	2.57	-1.14	-7.55	-6.02	3.57	0.56	8.30	-7.48
Enterprise Value (EV)	589	695	760	689	584	744	738	779	796	870
Market Capitalization	645	753	823	750	660	815	806	847	877	967
Book Value per Share	$10.80	$10.93	$10.99	$11.10	$11.15	$11.25	$11.38	$11.49	$11.69	$11.82
Tangible Book Value per Share	$0.81	$0.75	$0.90	$1.14	$1.30	$1.34	$1.59	$1.83	$2.10	$2.28
Total Capital	330	334	336	341	342	341	364	368	373	359
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	19	19	18	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	19	19	18	0.00
Net Debt	-56	-58	-63	-60	-76	-71	-68	-68	-81	-97
Capital Expenditures (CapEx)	5.96	6.14	8.45	6.25	6.72	6.60	7.76	6.71	6.84	6.84
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-53	-57	-55	-47	-60	-59	-62	-56	-60	-60
Debt-free Net Working Capital (DFNWC)	-1.04	-2.84	4.10	8.86	12	12	21	27	35	37
Net Working Capital (NWC)	-1.04	-2.84	4.10	8.86	12	12	21	27	35	37
Net Nonoperating Expense (NNE)	-1.89	-0.14	-0.21	-0.45	-0.42	-0.98	-0.68	-0.70	-0.75	-0.71
Net Nonoperating Obligations (NNO)	-56	-58	-63	-60	-76	-71	-68	-68	-81	-97
Total Depreciation and Amortization (D&A)	12	12	13	13	13	14	13	13	13	14
Debt-free, Cash-free Net Working Capital to Revenue	-20.14%	-21.27%	-20.17%	-17.19%	-21.48%	-21.24%	-22.04%	-19.55%	-20.77%	-20.50%
Debt-free Net Working Capital to Revenue	-0.40%	-1.06%	1.52%	3.23%	4.44%	4.25%	7.54%	9.55%	12.18%	12.83%
Net Working Capital to Revenue	-0.40%	-1.06%	1.52%	3.23%	4.44%	4.25%	7.54%	9.55%	12.18%	12.83%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.12	$0.08	$0.09	$0.13	$0.13	$0.15	$0.17	$0.14	$0.19	$0.16
Adjusted Weighted Average Basic Shares Outstanding	30.57M	30.65M	30.59M	30.68M	30.68M	30.57M	30.31M	30.40M	30.41M	30.39M
Adjusted Diluted Earnings per Share	$0.12	$0.08	$0.09	$0.13	$0.13	$0.15	$0.17	$0.14	$0.19	$0.16
Adjusted Weighted Average Diluted Shares Outstanding	30.66M	30.72M	30.66M	30.78M	30.77M	30.67M	30.42M	30.53M	30.59M	30.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	30.57M	30.58M	30.68M	30.69M	30.29M	30.30M	30.40M	30.41M	30.41M	30.43M
Normalized Net Operating Profit after Tax (NOPAT)	1.77	2.31	2.41	3.68	3.45	3.61	4.55	3.47	4.97	4.18
Normalized NOPAT Margin	2.64%	3.37%	3.50%	5.32%	4.90%	5.11%	6.25%	4.85%	6.80%	5.63%
Pre Tax Income Margin	7.32%	4.77%	4.56%	6.50%	7.75%	7.68%	8.99%	7.41%	10.23%	7.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	11.92%	17.60%	20.10%	21.93%	18.06%	16.78%	17.01%
Augmented Payout Ratio	304.11%	191.36%	0.00%	11.92%	30.21%	78.79%	21.93%	18.06%	53.72%	17.01%

Frequently Asked Questions About HealthStream's Financials

When does HealthStream's financial year end?

According to the most recent income statement we have on file, HealthStream's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has HealthStream's net income changed over the last 10 years?

HealthStream's net income appears to be on an upward trend, with a most recent value of $20.01 million in 2024, rising from $10.39 million in 2014. The previous period was $15.21 million in 2023.

What is HealthStream's operating income?

HealthStream's total operating income in 2024 was $21.29 million, based on the following breakdown:

Total Gross Profit: $193.71 million
Total Operating Expenses: $172.42 million

How has HealthStream revenue changed over the last 10 years?

Over the last 10 years, HealthStream's total revenue changed from $170.69 million in 2014 to $291.65 million in 2024, a change of 70.9%.

How much debt does HealthStream have?

HealthStream's total liabilities were at $151.41 million at the end of 2024, a 4.9% decrease from 2023, and a 69.4% increase since 2014.

How much cash does HealthStream have?

In the past 9 years, HealthStream's cash and equivalents has ranged from $36.57 million in 2020 to $134.32 million in 2018, and is currently $59.47 million as of their latest financial filing in 2024.

How has HealthStream's book value per share changed over the last 10 years?

Over the last 10 years, HealthStream's book value per share changed from 6.07 in 2014 to 11.82 in 2024, a change of 94.5%.

Remove Ads

Related Companies

This page (NASDAQ:HSTM) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthStream (HSTM) Financials

Frequently Asked Questions About HealthStream's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthStream (HSTM) Financials

Annual Income Statements for HealthStream

Quarterly Income Statements for HealthStream

Annual Cash Flow Statements for HealthStream

Quarterly Cash Flow Statements for HealthStream

Annual Balance Sheets for HealthStream

Quarterly Balance Sheets for HealthStream

Annual Metrics and Ratios for HealthStream

Quarterly Metrics and Ratios for HealthStream

Frequently Asked Questions About HealthStream's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools